PPARG and cancer: This is due to its comprehensive action on the pathways responsible for the development and progression of cancer, i.e., the Wnt/β-catenin pathway and PPARγ, as well as its effect on the cell cycle or inhibition of the proliferation of cancer stem cells, which are the main cause of CRC recurrence.